Tesaro News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.12.18	GBT On Fast Track, GH In Good Health, For BHVN, It's All Gain, No Pain (RTTNews)
03.12.18	Tesaro Agrees To Be Acquired By GSK For About $5.1 Bln, Incl. Debt (RTTNews)
20.10.18	TESARO Announces Data Presentations at ESMO 2018 Congress (GlobeNewswire)
16.10.18	Do You Have These Pharma Stocks In Your Portfolio? (EARS, BLRX, OMED...) (RTTNews)
05.09.18	BCRX At Its Zenith, CRON Walks The Walk, TSRO To Report Data In Nov. (RTTNews)
21.06.18	NEPT Hits A High, CLBS Up 118% In 2 Days, APEN Abuzz, Busy Days Ahead For TSRO (RTTNews)
05.06.18	FDA Approves First Neulasta Biosimilar, HQY Hits New High, TGTX Turns Heads (RTTNews)
03.06.18	An Ear To The Pharma: 9 Stocks To Watch (CTMX, ZEAL, MRSN...) (RTTNews)
01.06.18	TESARO Announces Addition of ZEJULA to Cancer Drugs Fund in UK (GlobeNewswire)
08.05.18	Psychological Effects of Ovarian Cancer Often Overlooked and Can Have a Significant Impact on Patients (GlobeNewswire)
11.04.18	TESARO and Medison Enter Into Exclusive Distribution Agreement to Commercialize ZEJULA® in Israel (GlobeNewswire)
11.03.18	An Ear To The Pharma: 4 Stocks To Watch This Week (RTTNews)
09.03.18	TESARO LEAD PLAINTIFF ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Tesaro Incorporated To Contact The Firm (PR Newswire)
23.02.18	EQUITY NOTICE: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against TESARO, Inc. - TSRO (PR Newswire)
17.02.18	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Tesaro Incorporated of Class Action Lawsuit and Upcoming Deadline - TSRO (PR Newswire)
15.02.18	In The Spotlight: AnaptysBio (RTTNews)
01.02.18	Kessler Topaz Meltzer & Check, LLP Announces Shareholder Class Action Filed Against Tesaro, Inc. - TSRO (PR Newswire)
19.01.18	SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Tesaro, Inc. (TSRO) and Lead Plaintiff Deadline: March 19, 2018 (PR Newswire)
17.01.18	TESARO INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Tesaro, Inc. To Contact The Firm (PR Newswire)
16.01.18	SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Tesaro, Inc. (TSRO) (PR Newswire)
16.01.18	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tesaro, Inc. - TSRO (PR Newswire)
20.11.17	TESARO Announces European Commission Approval of ZEJULA® for Women With Recurrent Ovarian Cancer (GlobeNewswire)
09.11.17	DEPO Building New Specialty Business, FPRX Rebounds, HALO Glows (RTTNews)
26.10.17	It's A No For PTCT As Expected, SRPT Revises Outlook Higher, TSRO Gets FDA Nod (RTTNews)
29.09.17	Biotech Stocks Facing FDA Decision In October (RTTNews)
18.09.17	FDA Nod For NEOS, One Step Closer To EU Approval Are GSK, TSRO, On Watch Is MTFB (RTTNews)
15.09.17	TESARO Receives Positive CHMP Opinion for ZEJULA® (GlobeNewswire)
11.09.17	TESARO Summarizes ZEJULA and TSR-042 Data Presented at the 2017 ESMO Annual Meeting (GlobeNewswire)
25.08.17	TESARO Announces Nine Data Presentations at the 2017 European Society for Medical Oncology (ESMO) Annual Meeting (GlobeNewswire)
07.08.17	Breakfast Technical Briefing on Biotech Stocks -- Sarepta Therapeutics, Trevena, Tesaro, and Vertex Pharma (PR Newswire)
27.07.17	TESARO and Takeda Enter Into Exclusive Licensing Agreement to Develop and Commercialize Novel Cancer Therapy Niraparib in Japan (GlobeNewswire)
14.07.17	Gainers & Losers Of July 13: PTX, ALDR, MNKD, TSRO, TOCA... (RTTNews)
06.07.17	Stocks Under Scanner in the Biotech Space -- Achillion Pharma, Kite Pharma, Acorda Therapeutics, and Tesaro (PR Newswire)
12.04.17	Research Reports Initiation on Biotech Stocks -- Tesaro, Alnylam Pharma, Corbus Pharma, and Inovio Pharma (PR Newswire)
28.03.17	FDA Nod For TSRO, Déjà Vu For ARQL, FOMX Plunges On Trial Data, SELB Abuzz (RTTNews)
28.03.17	Tesaro Announces FDA Approval Of Zejula For Women With Recurrent Ovarian Cancer (RTTNews)
27.03.17	TESARO Announces U.S. FDA Approval Of ZEJULA™ (Niraparib) For Women With Recurrent Ovarian Cancer (PR Newswire)
03.03.17	Learn how to target a 58% return on AveXis Inc., or get option-trade ideas on Ionis Pharmaceuticals, The Medicines Co, Prothena and Tesaro Inc. or any stock you choose (PR Newswire)
09.02.17	Gainers & Losers Of The Day: ATOS, APOP, TSRO, GALE, ACUR... (RTTNews)
31.01.17	Research Reports Initiation on Biotech Stocks -- Portola Pharma, Tesaro, Sangamo Therapeutics, and Cerus (PR Newswire)
26.01.17	Biotech Stocks Facing FDA Decision In February (RTTNews)
12.01.17	FDA Says No To TSRO, Ablynx On Track, MYL Leads In Herceptin Biosim Race In U.S. (RTTNews)
12.01.17	FDA Refuses To Approve Tesaro's Intravenous Formulation Of Rolapitant (RTTNews)
29.12.16	Biotech Stocks Facing FDA Decision In January (RTTNews)
22.12.16	Biotech Stocks on Investors' Radar -- Peregrine Pharma, Intrexon, Rexahn Pharma, and Tesaro (PR Newswire)
21.12.16	AKBA Inks Blockbuster Deal, AGN On Buying Spree, TSRO Gets FDA Date (RTTNews)
02.11.16	PTN Surges On Trial Data, PFE Dumps Cholesterol Drug, Watch Out For PRTA (RTTNews)
28.10.16	CEMP Plunges, ALDR Promises Data In 1H 2017, AERI Withdraws NDA, AZN, CYH Abuzz (RTTNews)
27.10.16	TESARO Announces Acceptance for Review of Niraparib Marketing Authorization Application by EMA (GlobeNewswire)
08.10.16	TESARO and ENGOT Announce Presentation of Successful Niraparib Phase 3 ENGOT-OV16/NOVA Trial Results During ESMO 2016 (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	31.13	2.91 %	K V
Geberit	505.80	2.47 %	K V
ABB	50.70	2.09 %	K V
Holcim	87.22	2.06 %	K V
CieFinRichemont	163.75	1.21 %	K V
Swisscom	512.50	0.10 %	K V
Sonova Hldg	302.60	-0.40 %	K V
Logitech Intl	79.70	-0.62 %	K V
Roche Hldg G	265.40	-1.19 %	K V
Novartis	89.32	-1.40 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Tesaro Inc

Aktien Top/Flop

Tesaro Peer Group Nachrichten

Meistgelesene Nachrichten